3

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: November 20, 2012
Period of Report: October 29, 2012
Accession Number: 0001437749-12-012014

View Document ↗ View on SEC.gov ↗